Seller record · Telehealth service

FORM by GBY

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the product pages, the peptide page, the terms or the privacy policy.

At a glance

FORM by GBYTelehealth service

7/8criteria passed

Price: Semaglutide $99 the first month, then $159 a month; tirzepatide $169, then $219
Sells: compounded semaglutide injection, compounded tirzepatide injection, and 15 more
FDA letters: None on file

Visit FORM by GBY See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth brand from a beauty studio company, selling compounded semaglutide and tirzepatide injections and tablets, a blend with B12 and glycine, bundled stacks, Wegovy and Zepbound memberships, and sermorelin, NAD+, glutathione and GHK-Cu. Care starts with a health survey, and its privacy policy names Vios Pharmacy in Michigan.

Operating entity No legal entity name appears in the footer, in the terms, in the privacy policy or in the telehealth consent; the terms say the platform is owned and operated by FORM by GBY, with no legal form.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	FORM by GBY's website; FORM by GBY's consent to telehealth page; FORM by GBY's physicians page
S2	Prescription gating	PASS	FORM by GBY's semaglutide page; FORM by GBY's shipping policy
S3	Pharmacy identification	PASS	FORM by GBY's privacy policy
S4	Compounding disclosure	PASS	FORM by GBY's semaglutide page; FORM by GBY's tirzepatide page; FORM by GBY's website
S5	Analytical documentation	FAIL	FORM by GBY's peptides page; FORM by GBY's semaglutide page; FORM by GBY's terms of service page
S6	Business address	PASS	FORM by GBY's terms of service page; FORM by GBY's privacy policy
S7	Price disclosure	PASS	FORM by GBY's semaglutide page; FORM by GBY's tirzepatide page; FORM by GBY's microdose tirzepatide page; FORM by GBY's page; FORM by GBY's metabolic page; FORM by GBY's Wegovy page; FORM by GBY's NAD+ page; FORM by GBY's sermorelin page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each intake and determines whether treatment is appropriate, and the telehealth consent says care is given by independent providers through Architek Health and Ovie Health Group.Source: FORM by GBY's website; FORM by GBY's consent to telehealth page; FORM by GBY's physicians page.

S2PASSThe start button on the semaglutide page opens an intake whose first screen is a health survey about goals and history, followed by medical review. The shipping policy says no order is processed or shipped until a provider has approved treatment.Source: FORM by GBY's semaglutide page; FORM by GBY's shipping policy.

S3PASSThe privacy policy names Vios Pharmacy, 31035 Schoolcraft Road, Livonia, MI 48150, as its pharmacy partner.Source: FORM by GBY's privacy policy.

S4PASSEvery compounded product page states that compounded medications are not FDA-approved and that the FDA does not review them for safety, effectiveness or quality. The footer says the brand primarily uses FDA-approved medications such as Wegovy and Zepbound.Source: FORM by GBY's semaglutide page; FORM by GBY's tirzepatide page; FORM by GBY's website.

S5FAILNo certificate of analysis or lot document is published on the product pages, the peptide page, the terms or the privacy policy.Source: FORM by GBY's peptides page; FORM by GBY's semaglutide page; FORM by GBY's terms of service page.

S6PASS6755 Badura Ave, Las Vegas, Nevada 89118, printed in the contact blocks of the terms and the privacy policy. The terms name Nevada law.Source: FORM by GBY's terms of service page; FORM by GBY's privacy policy.

S7PASSCompounded semaglutide injection at $99 for the first month, then $159 a month, and compounded tirzepatide at $169 for the first month, then $219. Microdose tirzepatide at $199 a month, oral semaglutide at $215 and oral tirzepatide at $299. The FORM3 blend with B12 and glycine prints semaglutide at $129 for the first month, then $199, and tirzepatide or microdose tirzepatide at $199 for the first month, then $299. Metabolic Duo plans at $299 and $399, stacks at $399, $449 and $499 a month, and Wegovy and Zepbound memberships at $95 a month with the medication bought through the manufacturers' pharmacy programs. NAD+ at $199, sermorelin at $249, glutathione at $199, GHK-Cu cream at $199 per unit, B12-MIC at $189 and finasteride at $89 a month.Source: FORM by GBY's semaglutide page; FORM by GBY's tirzepatide page; FORM by GBY's microdose tirzepatide page; FORM by GBY's page; FORM by GBY's metabolic page; FORM by GBY's Wegovy page; FORM by GBY's NAD+ page; FORM by GBY's sermorelin page.

S8PASSNo FDA warning letter names FORM by GBY, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, microdose tirzepatide, compounded oral semaglutide (ODT), compounded oral tirzepatide (ODT), FORM3 (tirzepatide or semaglutide with B12 and glycine), Metabolic Duo, FORM Era, FORM Foundation and FORM Restore stacks, Wegovy membership, Zepbound membership, NAD+, sermorelin injections, glutathione injections, GHK-Cu cream, B12-MIC injections, finasteride, oral and topical hair treatments.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells GHK-Cu

Visit FORM by GBY

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.